---
schema_version: "secwatch.filing_event.v1"
accession: "0001295947-22-000012"
form_type: "8-K"
ticker: "PBH"
cik: "0001295947"
company_name: "Prestige Consumer Healthcare Inc."
filed_at: "2022-05-05T23:59:59+00:00"
generated_at: "2026-06-25T23:25:06.808280+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Prestige Consumer Healthcare reports record FY2022 revenue $1.087B, adj. EPS $4.06, authorizes $50M buyback

## Summary
- Q4 revenue $266.9M (+12.3% YoY); full-year revenue $1,086.8M (+15.2% YoY).
- Full-year GAAP diluted EPS $4.04; adjusted diluted EPS $4.06, up 25.3%.
- Record non-GAAP free cash flow $253.7M; operating cash flow $259.9M.
- Initial FY2023 outlook: revenue ~$1.125B, diluted EPS $4.18-$4.23, FCF $260M+.
- Board authorized $50M share repurchase program through May 2023; net leverage 3.8x.

## SEC filing metadata
- accession: 0001295947-22-000012
- form_type: 8-K
- ticker: PBH
- cik: 0001295947
- company_name: Prestige Consumer Healthcare Inc.
- filed_at: 2022-05-05T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1295947/000129594722000012/0001295947-22-000012-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1295947/000129594722000012/pbh-20220505.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001295947-22-000012
- JSON: https://secwatch.observer/filing/0001295947-22-000012.json
- Plain text: https://secwatch.observer/filing/0001295947-22-000012.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.